Document is current
Any future updates will be listed below
-
Authors
Yohn, Samantha E.
Foster, Daniel J. https://orcid.org/0000-0002-5225-354X
Covey, Dan P.
Moehle, Mark S. https://orcid.org/0000-0002-8023-1313
Galbraith, Jordan
Garcia-Barrantes, Pedro M.
Cho, Hyekyung P.
Bubser, Michael
Blobaum, Anna L.
Joffe, Max E.
Cheer, Joseph F.
Jones, Carrie K.
Lindsley, Craig W.
Conn, P. Jeffrey
- License Information
-
More Information
Article History
Received: 29 December 2017
Revised: 1 June 2018
Accepted: 28 June 2018
First Online: 16 August 2018
Competing interests
: CWL and PJC are inventors on patents that protect different classes of metabotropic glutamate allosteric modulators. CWL has been funded by the NIH, Johnson and Johnson, Bristol-Myers Squibb, AstraZeneca, Michael J. Fox Foundation, as well as Seaside Therapeutics. He has consulted for AbbVie and received compensation. PJC has been funded by NIH, AstraZeneca, Bristol-Myers Squibb, Michael J. Fox Foundation, Dystonia Medical Research Foundation, CHDI Foundation, and Thome Memorial Foundation. Over the past three years he has served on the Scientific Advisory Boards for Michael J. Fox Foundation, Stanley Center for Psychiatric Research Broad Institute, Karuna Pharmaceuticals, Lieber Institute for Brain Development, Clinical Mechanism and Proof of Concept Consortium, and Neurobiology Foundation for Schizophrenia and Bipolar Disorder. SEY, DJF, DPC, MSM, JG, PMGB, HPC, MB, ALB, MEJ, JFC, and CKJ declare no potential conflicts of interest.
